Lilly(Eli) & Company
NYSE: LLY
$921.49
+$6.45 (+0.7%)
Closing Price on September 20, 2024
LLY Articles
At least once a year, and probably more often, a big drug company makes a settlement or faces suits over not disclosing the bad effects of one or more of its products. Lilly’s anti-psychotic drug...
Published:
We are right in the thick of earnings season and below is a snapshot of some of the key earnings reports with price changes if available: Air Tran (NYSE: AAI) -$0.02 EPS vs -$0.02 estimate. American...
Published:
Below is the top news that a673b.bigscoots-temp.com is focusing on that is impacting stocks in pre-market trading activity: Adobe Systems (ADBE) traded down 2% after beating earnings and slightly raised...
Published:
Last Updated:
Below is some of the top pre-market news affecting individual shares that a673b.bigscoots-temp.com is reviewing: AMERCO (NASDAQ: UHAL) announce a $50 million share buyback plan. Children’s Place Retail Stores...
Published:
ACA cut to Underperform at Credit Suisse.ACW raised to Neutral at UBS.AMSC started as Buy at Jefferies.ATPG cut to Underperform at RBC.BSC cut to Equal Weight at Lehman.BSY cut to Neutral at Merrill...
Published:
According to Reuters, Chuck Prince stepped down at CEO of Citigroup (C) and the bank indicated it may have to write off as much as another $11 billion. Reuters writes that shares of PetroChina (PTR)...
Published:
Plavix from Bristol-Myers (BMY) is the medical drug-thinner of choice. According to CNN Money, sales of the drug "totaled $3.4 billion in sales during the first nine months" Now Eli Lilly (LLY) has...
Published:
According to Reuters, Nestle increased its share buyback to $21 billion after reporting a strong first half. Reuters writes that SAP (SAP) and Dell (DELL) will create products that help retailers run...
Published:
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but its short...
Published:
Stock Tickers: MRK, PFE, JNJ, GSK, SGP, LLY, WYE, NVS, NVO On tonight’s MAD MONEY on CNBC, Jim Cramer said he keeps getting asked about Big Pharma drug stocks. He’d rather focus on farms, but...
Published:
Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April. Below is the...
Published: